logo
Share SHARE
FONT-SIZE Plus   Neg

FDA Grants Clearance To Quest Diagnostics' Simplexa C. Difficile Molecular Test

Quest Diagnostics (DGX) announced that the U.S. Food and Drug Administration has granted 510(k) clearance to its Simplexa C. difficile Universal Direct Test on the 3M Integrated Cycler.

The test, from the company's Focus Diagnostics business, is intended to aid in the diagnosis of Clostridium difficile-associated disease. It uses a proprietary technique to eliminate the time consuming nucleic-acid sample extraction process required by many other molecular tests, for potentially faster results reporting for hospitals and clinical laboratories.

Simplexa tests, running on the 3M Integrated Cycler, employ real-time polymerase chain reaction (RT-PCR) to qualitatively detect viruses, bacteria and other analytes. The Simplexa C. difficile Universal Direct test is performed on liquid or unformed human stool samples and detects the toxin B gene (tcdB) of C. difficile, including NAP1.

C. difficile-associated disease is a common and sometimes fatal healthcare-associated infection that causes diarrhea and other intestinal problems.

The company said that the Simplexa C. difficile Universal Direct Test on the 3M Integrated Cycler is immediately available in the United States. Focus Diagnostics launched the test in Europe during the second quarter of 2011.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
L'Oreal Co (LRLCY.PK) on Thursday reported an increase in profit for the first half of 2015, driven by growth in North America and new markets, and favorable currency helping results. The French cosmetics company said that on the back of comprehensive growth, it is making investments in the digital... Starwood Hotels & Resorts Worldwide, Inc. (HOT) said Thursday that its second quarter profit fell 11% from last year, hurt by lower revenue as well as restructuring and special charges. However, the company's quarterly earnings per share, excluding items, came in above analysst' expectations as did... Home buyers seem to be reaping the benefits of attractive mortgage rates, with the average 30-year fixed mortgage rate ducking just under four percent, a report from Freddie Mac said Thursday.
comments powered by Disqus
RELATED NEWS
Trade DGX now with 
Follow RTT